Adage Capital Partners’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-168,000
| Closed | -$5.58M | – | 892 |
|
|
2025
Q1 | $5.58M | Sell |
168,000
-332,000
| -66% | -$11M | 0.01% | 682 |
|
|
2024
Q4 | $17.2M | Buy |
500,000
+200,000
| +67% | +$6.88M | 0.03% | 475 |
|
|
2024
Q3 | $12M | Buy |
300,000
+250,000
| +500% | +$10M | 0.02% | 576 |
|
|
2024
Q2 | $1.51M | Sell |
50,000
-25,000
| -33% | -$754K | ﹤0.01% | 790 |
|
|
2024
Q1 | $2.52M | Sell |
75,000
-25,000
| -25% | -$840K | ﹤0.01% | 761 |
|
|
2023
Q4 | $3.23M | Sell |
100,000
-1,320,000
| -93% | -$42.6M | 0.01% | 720 |
|
|
2023
Q3 | $46.5M | Buy |
1,420,000
+220,000
| +18% | +$7.21M | 0.11% | 211 |
|
|
2023
Q2 | $42.2M | Sell |
1,200,000
-215,000
| -15% | -$7.57M | 0.09% | 223 |
|
|
2023
Q1 | $46.2M | Buy |
1,415,000
+1,285,000
| +988% | +$42M | 0.1% | 226 |
|
|
2022
Q4 | $7.16M | Sell |
130,000
-460,000
| -78% | -$25.3M | 0.02% | 707 |
|
|
2022
Q3 | $26.1M | Sell |
590,000
-444,450
| -43% | -$19.7M | 0.06% | 335 |
|
|
2022
Q2 | $50.5M | Sell |
1,034,450
-97,766
| -9% | -$4.77M | 0.12% | 185 |
|
|
2022
Q1 | $55.1M | Sell |
1,132,216
-617,784
| -35% | -$30.1M | 0.1% | 191 |
|
|
2021
Q4 | $74.6M | Buy |
1,750,000
+509,585
| +41% | +$21.7M | 0.13% | 159 |
|
|
2021
Q3 | $47.5M | Buy |
+1,240,415
| New | +$47.5M | 0.09% | 222 |
|